PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE) was the recipient of a large growth in short interest in February. As of February 15th, there was short interest totalling 36,200 shares, a growth of 1,710.0% from the January 31st total of 2,000 shares. Based on an average daily trading volume, of 35,300 shares, the days-to-cover ratio is presently 1.0 days.

PURE Bioscience Trading Down 4.5 %

Shares of PURE Bioscience stock opened at $0.06 on Friday. The firm has a market capitalization of $7.05 million, a PE ratio of -1.58 and a beta of 0.13. PURE Bioscience has a twelve month low of $0.06 and a twelve month high of $0.16. The firm’s 50-day moving average price is $0.07 and its 200 day moving average price is $0.08.

PURE Bioscience (OTCMKTS:PURE) last released its earnings results on Monday, December 16th. The company reported ($0.01) earnings per share for the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.